ArticleWorld journal of microbiology & biotechnology2026
Metabolic engineering of Dunaliella salina enhances astaxanthin production: combined effects of heterologous enzyme co-expression and dual-stress optimization.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Astaxanthin is primarily produced by chemical synthesis or extraction from Haematococcus pluvialis, but both approaches face limitations in cost, scalability, or product quality, necessitating alternative production platforms. To explore a potentially cost-effective alternative platform for astaxanthin production, we engineered Dunaliella salina by combinatorial expression of Haematococcus-derived β-carotene ketolase (BKT) and β-carotene hydroxylase (CRTR-B) isoenzymes. The optimal crtR-B1/bkt2 combination (P4 strain) yielded 44.3 µg/g astaxanthin under normal conditions, while also accumulating significant levels of other high-value carotenoids, including β-carotene (5.48 µg/mg) and lutein (1.54-fold higher than wild-type). Under complete nitrogen deficiency, the astaxanthin production of the P4 mutant strain reached 66.20 µg/g, while β-carotene, lutein, and canthaxanthin levels were 3.43-, 1.56-, and 1.75-fold higher than normal conditions, respectively. Dual-stress treatment, i.e., combination of nitrogen deprivation (0 mg/L NaNO₃) and high light intensity (15,000 lx), enhanced astaxanthin production to 89.56 µg/g in the P4 strain, with concurrent increases in canthaxanthin and β-carotene compared with normal culture conditions. Transcriptomic analysis revealed metabolic reprogramming with upregulation of carotenoid biosynthesis (BKT and LUT5), pyruvate metabolism, and photosynthesis genes, alongside downregulation of oxidative phosphorylation. This study demonstrates the combined optimization of isozyme combination and environmental stress to elevate the synthesis of astaxanthin and other carotenoids in D. salina, providing new research ideas and experimental evidence for the future construction of high-yield engineered algal strains.
Indexed as
Identifiers
42599600What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.